BlackRock Fund Advisors’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.88M Buy
12,454
+1,676
+16% +$391K ﹤0.01% 3175
2016
Q3
$3.48M Buy
10,778
+465
+5% +$170K ﹤0.01% 3017
2016
Q2
$3.36M Sell
10,313
-457
-4% -$157K ﹤0.01% 3026
2016
Q1
$3.61M Sell
10,770
-440
-4% -$150K ﹤0.01% 2907
2015
Q4
$4.36M Buy
11,210
+516
+5% +$202K ﹤0.01% 2906
2015
Q3
$4.38M Buy
10,694
+1,748
+20% +$915K ﹤0.01% 2865
2015
Q2
$6.54M Buy
8,946
+8,065
+915% +$5.72M ﹤0.01% 2762
2015
Q1
$432K Sell
881
-59
-6% -$25.2K ﹤0.01% 3290
2014
Q4
$291K Buy
940
+38
+4% +$12.3K ﹤0.01% 3378
2014
Q3
$297K Sell
902
-65
-7% -$19.5K ﹤0.01% 3339
2014
Q2
$244K Buy
967
+28
+3% +$8.97K ﹤0.01% 3419
2014
Q1
$388K Buy
939
+114
+14% +$49.3K ﹤0.01% 3290
2013
Q4
$341K Buy
825
+34
+4% +$15.1K ﹤0.01% 3281
2013
Q3
$409K Buy
791
+188
+31% +$107K ﹤0.01% 3219
2013
Q2
$304K Buy
+603
New +$273K ﹤0.01% 3214

Other funds holding CRDF